ArticleRadiology case reports2026
Asymmetric distribution of cerebral microbleeds in patient with infarction and atrophy: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral microbleeds (CMBs) are commonly associated with cerebral small vessel disease (CSVD) and cerebral amyloid angiopathy (CAA) and usually present bilaterally. Unilateral distribution is rare and challenges current understanding of disease pathophysiology. We report the case of an asymmetric distribution of cerebral microbleeds. A 69-year-old hypertensive woman presented with acute right-sided hemiparesis and aphasia. Magnetic resonance imaging revealed an acute left frontal infarction, multiple lobar CMBs exclusively in the left hemisphere, and progressive left hemispheric atrophy without significant large-vessel stenosis. Although CAA and CAA-related inflammation (CAA-ri) were considered, definitive diagnosis was precluded by absent histopathological confirmation and incomplete imaging criteria. The case was considered within the spectrum of cerebral small vessel disease, acknowledging the diagnostic uncertainty. The patient was managed conservatively with antithrombotic therapy and strict blood pressure control, with no recurrent ischemic or hemorrhagic events. During 3-year follow-up, no recurrent ischemic or hemorrhagic events occurred; however, progressive cognitive function declined (MMSE: 20→16→6) and mild unilateral cerebral atrophy developed, suggesting ongoing small-vessel-related pathology. This case highlights the diagnostic challenges posed by asymmetric CMB distribution and underscores the importance of careful longitudinal clinical and imaging follow-up in patients with atypical CSVD presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.